Expression of p53 in arsenic-related and sporadic basal cell carcinoma

Archives of Dermatology

Volumn 136, Issue 2, 2000, Pages 195-198

  Boonchai, Waranya ^a   Walsh, Michael ^b   Cummings, Margaret ^b   Chenevix Trench, Georgia ^a,b,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; PROTEIN P53;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033950326     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.2.195     Document Type: Article

References (27)

1. Miller SJ. Biology of basal cell carcinoma. I. J Am Acad Dermatol. 1991;24:1-13.
2. Vitaliano PP, Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol. 1980;116:454-456.
3. Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population. Am J Epidemiol. 1996;144:1034-1040.
4. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 1990;46:356-361.
5. Ouhtit A, Nakazawa H, Armstrong BK, et al. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst. 1998;90:523-531.
6. Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H. Characterization of p53 gene mutations in basal-cell carcinomas. Int J Cancer. 1996;65:778-780.
7. McNutt NS, Saenz-Santamaris C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 prolein expression in cutaneous disorders. Arch Dermatol. 1994; 130:225-232.
8. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993;90: 4216-4220.
9. Ponten F, Williams C, Ling G, et al. Genomic analysis of single cells from human basal cell cancer using laser-assisted capture microscopy. Mutat Res. 1997;382:45-55.
10. Moles JP, Moyret C, Guillot B, et al. p53 gene mutations in human epithelial skin cancers. Oncogene 1993;8:583-588.
11. Urano Y, Asano T, Yoshimoto K, et al. Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma. J Invest Dermatol. 1995;104:928-932.
12. Barrett TL, Smith KJ, Hodge JJ, Butler R, Hall FW, Skelton HG. Immunohistochemical nuclear staining for p53 PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J Am Acad Dermatol. 1997;37:430-437.
13. Rossman TG, Stone D, Molma M, Troll W. Absence of arsenite mutagenicity in E coli and Chinese hamster cells. Environ Mutagen. 1980;2:371-379.
14. Jha AN, Noditi M, Nilson R, Natarajan AT. Genotoxic effects of sodium arsenite on human cells. Mutat Res. 1992;248:215-221.
15. D'Errico M, Calcagnile AS, Corona R, et al. p53 mutations and chromosome instability in basal cell carcinomas developed at an early or late age. Cancer Res. 1997;57:747-752.
16. Hartwig A, Groblinghoff UD, Beyersmann D, Natarajan AT, Filon R, Mullenders LH. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis. 1997;18:399-405.
17. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promotor of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res. 1997;386:263-277.
18. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A. 1997;94:10907-10912.
19. Boonchai W, Green A, Ng J, Chenevix-Trench G. Basal cell carcinomas in chronic arsenism occurring in Queensland as a consequence of ingestion of an asthma medication J Am Acad Dermatol. In press.
20. Shi SR, Key ME, Kaira KL. Antigen retrival in formalin-fixed, paraffin-embedded tissues. J Histochem Cytochem. 1991;39:741-748.
21. Soong R, Robbins PD, Dix BR, et al. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol. 1996;27:1050-1055.
22. Lane DP, p53 and human cancers. Br Med Bull. 1994;50:582-599.
23. Chang C, Tsai R, Chen G, Yu H, Chai C. Expression of bcl-2. p53 and Ki-67 in arsenical skin cancers. J Cutan Pathol. 1998;25:457-462.
24. van der Riet P, Karp D, Farmer E, et al. Progression of basal cell carcinoma through loss of chromosome 9q and inaclivation of a single p53 allele. Cancer Res. 1994; 54:25-27.
25. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc. 1996;1:136-142.
26. De Rosa G, Staibano S, Barra E, et al. p53 protein in aggressive and non-aggressive basal cell carcinoma. J Cutan Pathol. 1993;20:429-434.
27. Sidransky D. Is human patched the gatekeeper of common skin cancers? Nat Genet. 1996;14:7-8.